Completed PHASE2 INTERVENTIONAL 2-arm NCT00467389

Use of Donepezil for Treatment of Cocaine Dependence

Donepezil Effects on Cocaine Craving and Pharmacokinetics

Sponsor: US Department of Veterans Affairs

Interventions Donepezil, 5 mg daily Oral Placebo

Updated 8 times since 2017 Last updated: May 21, 2014 Started: Feb 28, 2007 Primary completion: Sep 30, 2008 Completion: Sep 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cocaine Abuse and Dependence, this trial is completed. The trial is conducted by US Department of Veterans Affairs and has accumulated 8 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Aug 2018 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Aug 2018 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

US Department of Veterans Affairs

Data source: VA Office of Research and Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kansas City, United States